| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/13/2011 | US8017580 Therapies for chronic renal failure |
| 09/13/2011 | US8017579 Treatment of viral infections |
| 09/13/2011 | US8017578 Formulations of Activity Dependent Neurotrophic Factor (ADNF) polypeptide; use reducing neuronal cell death, oxidative stress, and fetal alcohol syndrome associated conditions |
| 09/13/2011 | US8017576 AMP-18 derived peptide to treat oral mucositis; Antrum Mucosal Protein (AMP)-18 (also called gastrokine-1); delays the onset or duration of mucositis, including cancer therapy-induced mucositis |
| 09/13/2011 | US8017575 Treatment of insulin resistance by modulating somatostatin using somatostatin receptor antagonists |
| 09/13/2011 | US8017574 identifying a Glucose-dependent Insulinotropic Peptide (GIP) secretagogue; G protein-coupled receptor (GPCR); useful as therapeutic agents for treating or preventing a condition characterized by low bone mass, such as osteoporosis |
| 09/13/2011 | US8017573 Adiponectin receptor fragments and methods of use |
| 09/13/2011 | US8017572 Immune-modulating peptide |
| 09/13/2011 | US8017571 Peptides derived from human BPLP protein |
| 09/13/2011 | US8017399 System and method for electroporating a sample |
| 09/13/2011 | US8017392 Hox11+, CD45− cells and methods of organ regeneration using the same |
| 09/13/2011 | US8017349 Human neuronal attachment factor-1 |
| 09/13/2011 | US8017347 Binder for C-reactive protein |
| 09/13/2011 | US8017343 Cytokine zalpha11 ligand antibodies and methods of use |
| 09/13/2011 | US8017168 High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
| 09/13/2011 | US8017156 Long-acting colloidal insulin formulation and its preparation |
| 09/13/2011 | US8017147 Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance |
| 09/13/2011 | US8017134 Recombinant toxin fragments |
| 09/13/2011 | US8017131 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 09/13/2011 | US8017125 Copolymers for suppression of autoimmune diseases, and methods of use |
| 09/13/2011 | US8017124 Use of the human protein Deleted in Malignant Brain Tumors 1 in the diagnosis, prophylaxis or treatment of diseases caused by an agent that has at least one accessible sulfate and/or phosphate group, such as a microorganism; ulcerative colitis; cancer of respiratory system or alimentary tract |
| 09/13/2011 | US8017121 Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
| 09/13/2011 | US8017117 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 09/13/2011 | CA2568352C Methods of using il-1 antagonists to treat autoinflammatory disease |
| 09/13/2011 | CA2557520C A method for stabilizing blood pressure in hemodialysis subjects |
| 09/13/2011 | CA2525873C Tumor cytotoxicity induced by modulators of the cxcr4 receptor |
| 09/13/2011 | CA2480276C Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 09/13/2011 | CA2465303C Compositions and methods for wt1 specific immunotherapy |
| 09/13/2011 | CA2396937C Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils |
| 09/13/2011 | CA2356836C Novel streptococcus antigens |
| 09/13/2011 | CA2351735C Engineered cytotoxic ribonuclease |
| 09/13/2011 | CA2334119C Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase |
| 09/13/2011 | CA2327587C Methods for treatment of haemophilia a patients using human anti-human fviii antibodies |
| 09/13/2011 | CA2297101C Receptor specific transepithelial transport of therapeutics |
| 09/13/2011 | CA2271690C Methods for regulating angiogenesis |
| 09/13/2011 | CA2236519C Methods of enhancing functioning of the large intestine |
| 09/09/2011 | WO2011109787A1 Methods of administering insulinotropic peptides |
| 09/09/2011 | WO2011109678A1 Modulation of intracellular signaling |
| 09/09/2011 | WO2011109588A1 Novel cd3 epsilon immunogens and antibodies |
| 09/09/2011 | WO2011109488A1 Hiv-1 envelope based fragments |
| 09/09/2011 | WO2011109448A1 Involvement of androgen/androgen receptor pathway in fabry disease |
| 09/09/2011 | WO2011109280A1 Methods and compositions to treat immune-mediated disorders |
| 09/09/2011 | WO2011108937A1 B-cell stimulating fusion proteins of an antigen with baff or april |
| 09/09/2011 | WO2011108796A1 Composition for preventing or treating cancer, containing letm1 |
| 09/09/2011 | WO2011108785A1 Peptide compound having inhibitory activity for infection or proliferation of orientia tsutsugamushi, and pharmaceutical composition for relieving scrub typhus using same |
| 09/09/2011 | WO2011108714A1 Antibody constant region variant |
| 09/09/2011 | WO2011108711A1 Model animal for pregnancy-induced hypertension syndrome, and treatment method therefor |
| 09/09/2011 | WO2011108692A1 Agent for preventing muscular atrophy |
| 09/09/2011 | WO2011108686A1 Substance derived from grifola frondosa for inhibiting increase of postprandial hyperglycemia |
| 09/09/2011 | WO2011108010A2 A thermostable liquid formulation of gonadotropins |
| 09/09/2011 | WO2011107591A1 Chimeric inhibitor molecules of complement activation |
| 09/09/2011 | WO2011107590A1 Cnn1 (cyr61) for prevention and therapy of inflammatory disease |
| 09/09/2011 | WO2011107505A1 Novel uses of elafin |
| 09/09/2011 | WO2011106991A1 One kind of complex molecules of protein polypeptide and application thereof |
| 09/09/2011 | WO2011106981A1 Use of cytokine-superantigen fusion protein for preparing medicament against solid tumor |
| 09/09/2011 | WO2011106898A1 Methods and systems for preparing irreversible inhibitors of protein tyrosine phosphatases |
| 09/09/2011 | WO2011106882A1 Target of egr1 (toe1 ) polypeptides for inhibition of hiv |
| 09/09/2011 | WO2011106839A1 Skin cancer prevention and treatment |
| 09/09/2011 | WO2011083153A3 Fibrinogen preparations enriched in fibrinogen with an extended alpha chain |
| 09/09/2011 | WO2011080102A3 Glp-1 analogues and derivatives |
| 09/09/2011 | WO2011075611A8 Compositions and methods for non-invasive treatment of chronic complications of diabetes |
| 09/09/2011 | WO2011063770A3 Immunomodulatory polypeptides derived from il- 2 and their use thereof in the therapeutic of cancer and chronic infections |
| 09/09/2011 | WO2011060409A3 Cullen 5 as a regulator of hsp90 clients : a new target for drug development |
| 09/09/2011 | WO2011038417A9 Methods to accelerate tissue and wound healing rates and reduce swelling and scar formation |
| 09/09/2011 | WO2010093904A9 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf |
| 09/09/2011 | CA2795698A1 Modulation of intracellular signaling |
| 09/09/2011 | CA2792161A1 Ep1 inhibition |
| 09/09/2011 | CA2791994A1 Involvement of androgen/androgen receptor pathway in fabry disease |
| 09/09/2011 | CA2791841A1 Chimeric inhibitor molecules of complement activation |
| 09/09/2011 | CA2791630A1 Combination pharmaceutical agents as inhibitors of hcv replication |
| 09/09/2011 | CA2791535A1 Methods and systems for preparing irreversible inhibitors of protein tyrosine phosphatases |
| 09/09/2011 | CA2791383A1 Compositions and methods for targeted immunomodulatory antibodies and fusion proteins |
| 09/09/2011 | CA2789742A1 Hiv-1 envelope based fragments |
| 09/09/2011 | CA2789073A1 Agent for preventing muscular atrophy |
| 09/08/2011 | US20110219464 Lung disease targets and uses thereof |
| 09/08/2011 | US20110218517 In vivo chemical stabilization of vulnerable plaque |
| 09/08/2011 | US20110218343 Small molecule inhibitors of rotamase enzyme activity |
| 09/08/2011 | US20110218333 Internalizing ErbB2 antibodies |
| 09/08/2011 | US20110218332 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 09/08/2011 | US20110218157 Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome |
| 09/08/2011 | US20110218156 Molecular entities for binding, stabilization and cellular delivery of negatively charged molecules |
| 09/08/2011 | US20110218155 Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides |
| 09/08/2011 | US20110218154 Histone deacetylases, and uses related thereto |
| 09/08/2011 | US20110218152 Compounds for stimulating p-glycoprotein function and uses thereof |
| 09/08/2011 | US20110218151 Substances for promoting healthy joint function comprising omega-3 polyunsaturated fatty acids or drivatives thereof, undenatured type ii collagen and, optionally, glucosamine sulfate |
| 09/08/2011 | US20110218150 Antiangiogenic polypeptides and methods for inhibiting angiogenesis |
| 09/08/2011 | US20110218149 Compositions and methods for treatment of kidney disorders |
| 09/08/2011 | US20110218148 Pharmaceutical composition |
| 09/08/2011 | US20110218147 Activin-actriia antagonists for inhibiting germ cell maturation |
| 09/08/2011 | US20110218146 Adiponectin for treating pulmonary disease |
| 09/08/2011 | US20110218145 Antibodies to modified human igf-1/e peptides |
| 09/08/2011 | US20110218144 Method of Reducing Deleterious Effects of Ischemia-Reperfusion |
| 09/08/2011 | US20110218143 Compositions and methods for tissue repair |
| 09/08/2011 | US20110218142 Inhibitors of Dipeptidylpeptidase IV |
| 09/08/2011 | US20110218141 Leptin therapy to increase muscle mass and to treat muscle wasting conditions |
| 09/08/2011 | US20110218140 Biodegradable therapeutic nanoparticles containing an antimicrobial agent |
| 09/08/2011 | US20110218139 Combination therapy and methods for treating bacterial biofilms |
| 09/08/2011 | US20110218138 Pharmaceutical composition containing polypeptide fragments of serralysins |
| 09/08/2011 | US20110217389 Methods for treating heat stress and related compositions |
| 09/08/2011 | US20110217380 Proteins that stimulate the secretion of satiety hormones |